IL17A and psoriasis: Our study demonstrates that HMGB1 can contribute to the pathogenesis of psoriasis by regulating Th17 cell differentiation through the HMGB1‐TLR4‐IL‐23‐RORγt pathway, then promote IL‐17A production and aggravate inflammation process.